How Pfizer Aims to Build Its Brand Post Pandemic

The company is preparing for 19 product launches in the next 18 months

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

CANNES, France—Over the course of the pandemic, Pfizer has become a global household name thanks to its development of a Covid-19 vaccine.

Producing thousands of medicines and healthcare products, the company is implementing a strategy to grow its brand recognition under its first-ever CMO, Andreas Panayiotou. He joined in September 2022 and aims to build more creativity and storytelling into the pharma giant’s communications output, while highlighting its science-based products in simple ways.

“The Pfizer brand is all about the power of science,” said Angela Hwang, chief commercial officer, who joined Panayiotou for an interview with Adweek in Cannes.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in